Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2023-08-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
第三届监事会第十八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting date, attendance, and voting results on several agenda items including approval of the 2023 semi-annual report, profit distribution plan, special report on raised funds usage, and nomination of new supervisory board members. The document references other filings where the full semi-annual report and related announcements are published, indicating this document itself is not the full report but a meeting resolution announcement. The document length is short (1960 characters) and it mainly announces decisions and approvals rather than providing detailed financial data or the full report. Therefore, it is best classified as a Regulatory Filing (RNS) since it does not contain the full semi-annual report or detailed financial statements but is a formal announcement of supervisory board resolutions related to those reports and other corporate governance matters.
2023-08-23 Chinese
关于召开2023年第一次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2023 first extraordinary general meeting of shareholders (临时股东大会通知公告) for Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting date, voting methods, agenda items including profit distribution and board and supervisory committee elections, and registration procedures. It does not contain financial statements or results but is an announcement about the meeting and its agenda. The document length is 3771 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-08-23 Chinese
独立董事候选人声明 （万勇）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate (Wan Yong) for Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. The content is a statement related to board membership qualifications rather than a report, financial data, or announcement of voting results. It does not fit categories like Annual Report, Audit Report, or Management Reports. It is an announcement related to board/management information, specifically about a director candidate's declaration. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on a single candidate's declaration, consistent with MANG filings.
2023-08-23 Chinese
独立董事候选人声明 （赵强）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate (赵强) for a company listed on the Beijing Stock Exchange. It details the candidate's qualifications, compliance with regulatory requirements, independence criteria, and commitments related to the role of an independent director. There are no financial statements, earnings data, or report summaries. The document is a regulatory announcement related to board/management information, specifically about a director candidate's declaration. It is not a full report, audit, or financial filing. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on a single candidate's declaration, consistent with management information announcements.
2023-08-23 Chinese
第三届董事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 24th meeting of the third board of directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting attendance, voting results on various proposals including approval of the 2023 semi-annual report, profit distribution plan, board member nominations, and other corporate governance matters. The document references other filings for detailed reports but itself is a summary of board decisions and nominations. This fits the category of Board/Management Information (MANG), as it announces changes and decisions related to the company's board of directors and management structure. The document length is 3350 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is MANG with high confidence.
2023-08-23 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2022 annual equity distribution (dividend) plan by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the dividend amount, payment dates, tax treatment, and record dates. It references the shareholders' meeting approval but does not contain financial statements or detailed financial performance data. The document length is short (1256 characters) and it is clearly an announcement of dividend distribution details rather than a full annual report or financial statement. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-05-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.